The Swiss pharma company presented results from its coopERA trial of giredestrant in post-menopausal women with hormone receptor (HR)-positive, HER2-negative early breast cancer at the ESMO ...

Roche meanwhile already has the comfort of one positive result for giredestrant from the coopERA study in post ... which was reported at last year's ESMO meeting. In that trial, the SERD performed ...

Here you will find news stories and blog posts about the research our scientists have presented at the congress over the years. ESMO Virtual Plenary 2022: Major trial shows targeted drug improves ...

Leaders from the Shanghai Coopera­tion Organisation (SCO) member states will convene in the federal capital next week for the 23rd meeting of the Cou­ncil of the Heads of Gover­nment (CHG ...